All articles by Linda Stewart – Page 41
-
NewsWhat drives food allergies? New study pinpoints early-life factors that raise risk - including microbiome
A new study involving 2.8 million children around the world has revealed the most important early-life factors that influence whether a child becomes allergic to food. Genetics alone cannot fully explain food allergy trends, pointing to interactions between genes, skin health, the microbiome, and environmental exposures.
-
NewsCommunity spread drives ongoing measles transmission in Europe
Preliminary data for 2025 show a significant drop in the number of reported measles cases across EU/EEA countries compared with 2024. However, these figures are still twice as high than those reported in 2023.
-
NewsEthris and German Center for Infection Research (DZIF) announce strategic collaboration to develop mRNA-based vaccines
Ethris GmbH, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, and the German Center for Infection Research (DZIF), have announced a strategic research collaboration to develop mRNA-based vaccines for the prevention and treatment of infectious diseases.
-
NewsScientists uncover link between influenza and heart disease
Researchers have identified a cellular mechanism linking infections from influenza A viruses (IAVs) to cardiovascular disease, providing critical insights on how influenza can damage the heart and increase the risk of a heart attack or other major cardiovascular event.
-
NewsH5N1 causes die-off of Antarctic skuas
More than 50 skuas in Antarctica died from the high pathogenicity avian influenza virus H5N1 in the summers of 2023 and 2024, marking the first documented die-off of wildlife from the virus on the continent.
-
NewsScientists explain why methane spiked in the early 2020s
A combination of weakened atmospheric removal and increased emissions from warming wetlands, rivers, lakes, and agricultural land increased atmospheric methane at an unprecedented rate in the early 2020s, an international team of researchers report.
-
NewsPathogen risk: Removing southern African fences may help wildlife, boost economy
Fences intended to protect cattle from catching diseases from wildlife and other livestock in southern Africa are in disrepair, restrict wild animal migrations and likely intensify human-elephant conflict – but a plan to remove key sections could make both livestock and wildlife safer.
-
NewsNext generation genetics technology developed to counter the rise of antibiotic resistance
The new Pro-Active Genetics (Pro-AG) tool called pPro-MobV is a second-generation technology that uses an approach similar to gene drives to disable drug resistance in populations of bacteria.
-
NewsResearchers discover that vaginal bacteria don’t always behave the same way
By analyzing vaginal microbiome data at unprecedented resolution, researchers have identified 25 distinct vaginal microbiome types and demonstrated that bacteria of the same species can differ substantially in their functional potential, thereby affecting how these microbes interact with the body.
-
NewsA standout solvent for today’s biorefineries
Researchers tested multiple distillable amine-based solvents to see how they performed in pretreatment processes for biomass. They found butylamine was a superior solvent.
-
NewsTeam finds E. coli, other pathogens in Potomac River after sewage spill
Following one of the largest sewage spills in U.S. history, researchers detected high levels of fecal-related bacteria and disease-causing pathogens in the Potomac River, raising urgent public health concerns and underscoring the risks posed by aging sewer infrastructure.
-
NewsResearchers on the cusp of a vaccine for a global health threat
Researchers are on the cusp of a new vaccine to prevent chikungunya, a global health threat which attacks human joint tissue. The team tested whether they could engineer E. coli to assemble biopolymer particles which displayed chikungunya antigens and performed as a vaccine.
-
NewsConstruction of a localized immune niche via supramolecular hydrogel vaccine to elicit durable and enhanced immunity against infectious diseases
A new article discusses the construction of a localized immune niche via supramolecular hydrogel vaccine to elicit durable and enhanced immunity against infectious diseases.
-
NewsDiscovery of SARS-CoV-2 PLpro inhibitors and RIPK1 inhibitors with synergistic antiviral efficacy in a mouse COVID-19 model
A new article publication discusses the discovery of SARS-CoV-2 PLpro inhibitors and RIPK1 inhibitors with synergistic antiviral efficacy in a mouse COVID-19 model.
-
NewsNew study reveals cyanobacteria may help spread antibiotic resistance in estuarine ecosystems
Scientists have discovered that cyanobacteria may play a major role in spreading antibiotic resistance genes in coastal environments. The findings highlight a previously overlooked link between natural nutrient cycling and the global challenge of antibiotic resistance.
-
NewsTaxiing through the gut: Formic acid in the microbiome
Scientists have found that the gut bacterium Blautia luti produces formic acid (formate) instead of carbon dioxide (CO₂) and hydrogen, with hydrogen bound to CO₂. In this case, formic acid is the electron taxi, allowing the energetically costly production of hydrogen to be bypassed.
-
NewsLarge-scale study analyses the impact of climate on Legionnaires’ disease in Catalonia
A study has analysed the relationship between climatic conditions, the presence of Legionella in water systems and cases of Legionnaires’ disease in Catalonia. The link between these different factors highlights the need to adapt prevention and surveillance strategies in the context of climate change.
-
NewsNew study: Immune cells linked to Epstein-Barr virus may play a role in MS
Researchers have found that certain types of CD8+ “killer” T cells — immune cells that destroy damaged or infected cells — are more abundant in people with MS. Some of these killer T cells target EBV, which suggests that the virus may trigger the damaging immune response seen in MS.
-
NewsCARB-X to support development of typhoid fever diagnostic from Chembio
CARB-X is awarding US$1.8 million to Chembio Diagnostic Systems, Inc. to develop a rapid point-of-care test for the detection of Immunoglobulin A (IgA) antibodies to diagnose acute infection of Salmonella enterica serovar Typhi.
-
NewsStudy reveals dual forces driving SARS-CoV-2 evolution: Immune pressure and viral fitness
New research clarifies the complex role of neutralizing antibodies in shaping disease outcomes and the evolution of SARS-CoV-2.